Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes

被引：25
|
作者：
Reznik, Y. [1 ]
机构：
[1] CHU Cote Nacre, Serv Endocrinol & Malad Metab, F-14033 Caen, France
来源：
DIABETES & METABOLISM | 2010年 / 36卷 / 06期
关键词：
External insulin pump; CSII; Type; 2; diabetes; Intensified insulin therapy; HbA(1c); Diabetes; Review; MULTIPLE DAILY INJECTIONS; BETA-CELL FUNCTION; GLYCEMIC CONTROL; CLINICAL-TRIAL; PARALLEL-GROUP; THERAPY; MELLITUS; SECRETION; WITHDRAWAL; ANALOGS;
D O I：
10.1016/j.diabet.2010.08.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Continuous subcutaneous insulin infusion (CSII) using an external pump is widely used for the treatment of type 1 diabetes, but has been less evaluated in type 2 diabetes. This review analyzes the open-label as well as randomized controlled studies performed in type 2 diabetic patients. The efficacy of CSII is compared with multiple daily injections (MDI) in terms of glycaemic control, weight variation, insulin requirements, treatment satisfaction and hypoglycaemic events. CSII may be offered as an alternative treatment to type 2 diabetic patients with poor glycaemic control despite high-dose insulin requirements administered through MDI. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：415 / 421
页数：7
相关论文
共 50 条
12345